Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticonvulsants in bipolar disorder.

Vivek Singh1, David J Muzina, Joseph R Calabrese

  • 1Department of Psychiatry, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive (Mail Code 7792), San Antonio, TX 78229, USA. singhv@uthscsa.edu

The Psychiatric Clinics of North America
|April 14, 2005
PubMed
Summary

Anticonvulsants like divalproex (DIV) and carbamazepine (CBZ) show promise for acute mania, while lamotrigine (LAM) is effective for bipolar depression. More research is needed for long-term bipolar disorder management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and factors associated with fatigue in patients with major depressive disorder or bipolar disorder.

Journal of affective disorders·2024
Same author

Differential contributions of circadian clock genes to cell survival in bipolar disorder patient derived neuronal progenitor cells distinguishes lithium responders and non-responders.

Research square·2024
Same author

Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder.

Nature genetics·2024
Same author

Possible Role of Correlation Coefficients and Network Analysis of Multiple Intracellular Proteins in Blood Cells of Patients with Bipolar Disorder in Studying the Mechanism of Lithium Responsiveness: A Proof-Concept Study.

Journal of clinical medicine·2024
Same author

Discovery of 95 PTSD loci provides insight into genetic architecture and neurobiology of trauma and stress-related disorders.

medRxiv : the preprint server for health sciences·2023
Same author

Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2023

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Anticonvulsants are increasingly investigated for mood-stabilizing properties in bipolar illness.
  • These agents exhibit heterogeneous mechanisms of action and varying efficacy across mood states.

Purpose of the Study:

  • To review the current evidence for anticonvulsant efficacy in managing acute and long-term bipolar disorder.
  • To identify gaps in knowledge and guide future research for improved treatment strategies.

Main Methods:

  • Systematic review of controlled studies on anticonvulsants in bipolar disorder.
  • Analysis of efficacy data for specific agents in mania, depression, and prophylaxis.

Main Results:

  • Divalproex (DIV) and carbamazepine (CBZ) are supported for acute mania; DIV shows superiority in mixed mania.

Related Experiment Videos

  • Lamotrigine (LAM) demonstrates efficacy in bipolar depression and rapid cycling, with proven prophylactic benefits.
  • Evidence for other anticonvulsants (e.g., OXC, GBP) in long-term management is limited or lacking.
  • Conclusions:

    • DIV and LAM are valuable options for specific bipolar disorder presentations (acute mania, depression, rapid cycling).
    • Current evidence is insufficient for many anticonvulsants in long-term bipolar disorder management.
    • Larger, rigorous studies are essential to expand the therapeutic armamentarium for bipolar disorder.